AT497973T - Recombinant production heparin binding proteins - Google Patents

Recombinant production heparin binding proteins

Info

Publication number
AT497973T
AT497973T AT06850998T AT06850998T AT497973T AT 497973 T AT497973 T AT 497973T AT 06850998 T AT06850998 T AT 06850998T AT 06850998 T AT06850998 T AT 06850998T AT 497973 T AT497973 T AT 497973T
Authority
AT
Austria
Prior art keywords
binding proteins
recombinant production
heparin binding
heparin
recombinant
Prior art date
Application number
AT06850998T
Other languages
German (de)
Inventor
Michelle D Butler
Jeffrey L Cleland
David W Kahn
Shelly Pizarro
Charles H Schmelzer
Marjorie E Winkler
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US75361505P priority Critical
Priority to US80743206P priority
Application filed by Genentech Inc filed Critical Genentech Inc
Priority to PCT/US2006/062320 priority patent/WO2007130154A2/en
Publication of AT497973T publication Critical patent/AT497973T/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
AT06850998T 2005-12-22 2006-12-19 Recombinant production heparin binding proteins AT497973T (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US75361505P true 2005-12-22 2005-12-22
US80743206P true 2006-07-14 2006-07-14
PCT/US2006/062320 WO2007130154A2 (en) 2005-12-22 2006-12-19 Recombinant production of heparin binding proteins

Publications (1)

Publication Number Publication Date
AT497973T true AT497973T (en) 2011-02-15

Family

ID=38668202

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06850998T AT497973T (en) 2005-12-22 2006-12-19 Recombinant production heparin binding proteins

Country Status (17)

Country Link
US (3) US20080032343A1 (en)
EP (2) EP1973942B1 (en)
JP (2) JP5036727B2 (en)
KR (1) KR101067525B1 (en)
AR (1) AR058625A1 (en)
AT (1) AT497973T (en)
AU (1) AU2006343279B2 (en)
BR (1) BRPI0621124A2 (en)
CA (1) CA2633554C (en)
DE (1) DE602007012412D1 (en)
HK (1) HK1119188A1 (en)
IL (1) IL191968A (en)
MY (1) MY143274A (en)
NZ (1) NZ568809A (en)
RU (1) RU2385877C1 (en)
TW (1) TWI369362B (en)
WO (1) WO2007130154A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1973942B1 (en) 2005-12-22 2011-02-09 Genentech, Inc. Recombinant production of heparin binding proteins
AU2007272412B2 (en) 2006-07-14 2013-11-07 Genentech, Inc. Refolding of recombinant proteins
WO2010059232A1 (en) 2008-11-20 2010-05-27 Biogen Idec Ma Inc. Arginine inactivation of viruses
WO2011005488A1 (en) 2009-06-22 2011-01-13 Amgen Inc. Refolding proteins using a chemically controlled redox state
WO2010151688A2 (en) 2009-06-25 2010-12-29 Amgen Inc. Capture purification processes for proteins expressed in a non-mammalian system
SG10201606027VA (en) 2010-02-25 2016-09-29 John Clement Preston Scaffolding

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4169950A (en) * 1977-12-08 1979-10-02 Research Organics Amino-hydroxy-alkyl sulfonic acid zwitterions
US4263428A (en) 1978-03-24 1981-04-21 The Regents Of The University Of California Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same
US4565785A (en) 1978-06-08 1986-01-21 The President And Fellows Of Harvard College Recombinant DNA molecule
ZA8101368B (en) 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
EP0052322B1 (en) 1980-11-10 1985-03-27 Gersonde, Klaus, Prof. Dr. Method of preparing lipid vesicles by ultrasonic treatment, the use of this method and apparatus for its application
US4485045A (en) 1981-07-06 1984-11-27 Research Corporation Synthetic phosphatidyl cholines useful in forming liposomes
JPS58118008A (en) 1982-01-06 1983-07-13 Nec Corp Data processor
EP0088046B1 (en) 1982-02-17 1987-12-09 Ciba-Geigy Ag Lipids in the aqueous phase
DE3218121A1 (en) 1982-05-14 1983-11-17 Leskovar Peter Dr Ing Pharmaceutical compositions for tumour treatment
EP0102324A3 (en) 1982-07-29 1984-11-07 Ciba-Geigy Ag Lipids and surfactants in an aqueous medium
US4673641A (en) 1982-12-16 1987-06-16 Molecular Genetics Research And Development Limited Partnership Co-aggregate purification of proteins
US4511502A (en) 1982-12-22 1985-04-16 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4512922A (en) * 1982-12-22 1985-04-23 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4511503A (en) 1982-12-22 1985-04-16 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4544545A (en) 1983-06-20 1985-10-01 Trustees University Of Massachusetts Liposomes containing modified cholesterol for organ targeting
US4710473A (en) 1983-08-10 1987-12-01 Amgen, Inc. DNA plasmids
DE3486459D1 (en) 1983-09-26 1997-12-11 Udo Dr Med Ehrenfeld Means and product for the diagnosis and therapy of tumors and for the treatment of weaknesses of the cellular and humoral immune defense
DE3474511D1 (en) 1983-11-01 1988-11-17 Terumo Corp Pharmaceutical composition containing urokinase
US4795706A (en) * 1985-01-31 1989-01-03 Eli Lilly And Company Novel expression control sequences
ES8800957A1 (en) 1985-02-22 1987-12-01 Monsanto Co A method for solubilization and renaturation of somatotropin protein
US5453363A (en) * 1985-10-23 1995-09-26 Boehringer Mannheim Gmbh Process for the activation of t-PA or Ing after genetic expression in prokaryotes
AU614137B2 (en) 1988-06-06 1991-08-22 Takeda Chemical Industries Ltd. Stabilized fgf composition and production thereof
DE3835350A1 (en) * 1988-10-17 1990-04-19 Boehringer Mannheim Gmbh Activation of genetically manufactured antibody expressed in prokaryons
US5332671A (en) * 1989-05-12 1994-07-26 Genetech, Inc. Production of vascular endothelial cell growth factor and DNA encoding same
US5194596A (en) 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor
US5288931A (en) * 1991-12-06 1994-02-22 Genentech, Inc. Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation
US5304472A (en) 1992-11-20 1994-04-19 Genentech, Inc. Method of controlling polypeptide production in bacterial cells
US5342763A (en) 1992-11-23 1994-08-30 Genentech, Inc. Method for producing polypeptide via bacterial fermentation
AT195652T (en) 1992-12-02 2000-09-15 Alkermes Inc Growth hormone-containing microsphere controlled-release
EP0831787B1 (en) 1995-06-07 2001-08-22 Alkermes Controlled Therapeutics, Inc. Composition for sustained release of human growth hormone
US5331095A (en) 1993-04-12 1994-07-19 Scios Nova Inc. Process for purification of basic fibroblast growth factor
JP4098372B2 (en) * 1993-07-28 2008-06-11 三菱化学株式会社 Process for the production of heparin-binding growth factor
US5663304A (en) 1993-08-20 1997-09-02 Genentech, Inc. Refolding of misfolded insulin-like growth factor-I
US5464815A (en) 1993-09-08 1995-11-07 Genentech, Inc. Inhibition of heparin-binding
AU696764B2 (en) * 1994-03-08 1998-09-17 Human Genome Sciences, Inc. Vascular endothelial growth factor 2
NZ292263A (en) 1994-09-09 1998-12-23 Takeda Chemical Industries Ltd Sustained release preparations comprising a polyvalent metal salt of water-soluble peptide and a biodegradable polymer
FR2729972B1 (en) * 1995-01-31 1997-04-18 Sanofi Sa Method periplasmic proteins extraction of prokaryotic microorganisms in the presence of arginine
ZA9605368B (en) 1995-07-14 1997-01-14 Novo Nordisk As A pharmaceutical formulation
US6632425B1 (en) * 1997-03-20 2003-10-14 Human Genome Sciences, Inc. Chemokine compositions
US6750044B1 (en) 1996-10-17 2004-06-15 Genentech, Inc. Variants of vascular endothelial cell growth factor having antagonistic properties, nucleic acids encoding the same and host cells comprising those nucleic acids
DE19735711C2 (en) 1997-08-18 2001-04-26 Aventis Pharma Gmbh A process for preparing a precursor of insulin or insulin derivatives having correctly linked cystine bridges
US6653098B1 (en) 1998-02-23 2003-11-25 G. D. Searle & Co. Method of producing mouse and human endostatin
AU765574B2 (en) 1998-03-31 2003-09-25 Tonghua Gantech Biotechnology Ltd. Chimeric protein containing an intramolecular chaperone-like sequence and its application to insulin production
DK1084136T3 (en) 1998-06-01 2005-01-03 Genentech Inc Separation of the monomers of an antibody from its multimers by use of ion-exchange chromatography
AT415469T (en) 1998-10-28 2008-12-15 Genentech Inc A process for recovering heterologous polypeptide from bacterial cells
US6783953B1 (en) * 1998-12-22 2004-08-31 Janssen Pharmaceutica N.V. Vascular endothelial growth factor-X
EP1183357A2 (en) * 1999-05-20 2002-03-06 Scios Inc. Vascular endothelial growth factor dimers
CA2397773C (en) 2000-01-25 2008-09-02 Oklahoma Medical Research Foundation Universal procedure for refolding recombinant proteins
AUPQ568100A0 (en) * 2000-02-16 2000-03-09 Amrad Operations Pty. Limited A method for producing recombinant molecules
AU4464701A (en) * 2000-03-30 2001-10-15 Takeda Chemical Industries Ltd Process for producing recombinant protein
CA2408851C (en) 2000-05-16 2011-07-12 Bolder Biotechnology, Inc. Methods for refolding proteins containing free cysteine residues
US7611711B2 (en) * 2001-01-17 2009-11-03 Vegenics Limited VEGFR-3 inhibitor materials and methods
SK10472003A3 (en) 2001-02-23 2004-03-02 Immunex Corporation Efficient recovery of correctly refolded proteins
WO2003094617A2 (en) 2002-05-06 2003-11-20 Genentech, Inc. Use of vegf for treating bone defects
EP2430923A1 (en) 2002-06-05 2012-03-21 Genentech, Inc. Compositions and methods for liver growth and liver protection
CA2511946A1 (en) 2003-01-09 2004-10-28 Genentech, Inc. Purification of polypeptides
EP1449848A1 (en) 2003-02-20 2004-08-25 GBF German Research Centre for Biotechnology Method for the production of cystine-knot proteins
JP4477013B2 (en) 2003-12-10 2010-06-09 イーライ リリー アンド カンパニー Muteins of fibroblast growth factor 21
DE102004015965A1 (en) 2004-04-01 2005-10-20 Aventis Pharma Gmbh A process for obtaining insulin by improved air gassing of the folding
US8362206B2 (en) 2004-06-28 2013-01-29 Yeda Research And Development Co. Ltd. Chimeric proteins and uses thereof
CA2587948A1 (en) 2004-11-22 2006-05-26 Borean Pharma Aps Tnf antagonists
EP1698637B1 (en) * 2005-03-03 2008-10-15 Ajinomoto Co., Inc. A method for improving recovery yield in protein purification with gel filtration chromatography using arginine
EP1973942B1 (en) 2005-12-22 2011-02-09 Genentech, Inc. Recombinant production of heparin binding proteins

Also Published As

Publication number Publication date
WO2007130154A8 (en) 2008-04-17
KR20080087128A (en) 2008-09-30
CA2633554C (en) 2012-11-13
BRPI0621124A2 (en) 2011-11-29
JP5036727B2 (en) 2012-09-26
AU2006343279B2 (en) 2012-03-29
MY143274A (en) 2011-04-15
US20080032343A1 (en) 2008-02-07
AR058625A1 (en) 2008-02-13
IL191968A (en) 2013-06-27
RU2008130072A (en) 2010-01-27
NZ568809A (en) 2011-08-26
EP2336164A1 (en) 2011-06-22
EP1973942A2 (en) 2008-10-01
AU2006343279A1 (en) 2007-11-15
US20130217867A1 (en) 2013-08-22
HK1119188A1 (en) 2011-07-15
IL191968D0 (en) 2008-12-29
TWI369362B (en) 2012-08-01
JP2011254831A (en) 2011-12-22
KR101067525B1 (en) 2011-09-27
EP1973942B1 (en) 2011-02-09
WO2007130154A3 (en) 2008-06-26
US8906648B2 (en) 2014-12-09
WO2007130154A2 (en) 2007-11-15
DE602007012412D1 (en) 2011-03-24
JP2009521232A (en) 2009-06-04
US20100261888A1 (en) 2010-10-14
CA2633554A1 (en) 2007-11-15
RU2385877C1 (en) 2010-04-10
TW200734351A (en) 2007-09-16

Similar Documents

Publication Publication Date Title
AT408603T (en) pyrazolylcarboxanilides
AT446040T (en) Handstaubsauger
AT498360T (en) Ösennahtanker
CR10775A (en) Zin finger proteins noncanonical optimized
DE602006017202D1 (en) Pegylated glp-1 connections
AT462445T (en) Prrs-vaccines
AT489405T (en) Hybridcopolymere
AT485852T (en) Oberflächeninjizierungsvorrichtung
DK1951730T3 (en) Heteroalkylbundne pyrimidine
DE602006020996D1 (en) Hreren inputs
AT385404T (en) support element
AT529505T (en) subtilase variants
DE602005016917D1 (en) Fgf-21 fusion proteins
DOP2006000278A (en) Glycosylation in the variable region
AT533787T (en) Hepatocyte growth factor (HGF) binding proteins
DK2046826T3 (en) Exendin-fusion proteins
AT465368T (en) tilting means
AT477250T (en) Cyanoanthranilamidinsektizide
DK1833331T3 (en) Restaurant System
AT469305T (en) compressor
AT444717T (en) Lasermikroporator
AT496729T (en) Schleifagglomeratpolierverfahren
NO343547B1 (en) Interleukin-13 binding proteins
AT443720T (en) Fc-interferon-beta fusion proteins
DE602005024857D1 (en) fusion proteins

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Country of ref document: EP

Ref document number: 1973942